Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), whic…
Biotechnology
US, Florham Park [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Cellectar Biosciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCellectar Biosciences, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Cellectar Biosciences, Inc..
If you want to see a demo, head over to the financial segments of AAPL